Guyer Charles Greg's Form 4 filing
Biomarin Pharmaceutical Inc (BMRN) · filed Aug 10, 2023
- Accession no.
- 0001048477-23-000035
- Filed
- Aug 10, 2023
- Trade date
- Aug 9, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $500.1K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Guyer Charles GregCIK 0001811096 | Officer (EVP, Chief Technical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 9, 2023 | Common Stock | SSaleDisposed | −5,360 | $93.30 | −$500,088 | 40,041 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.